Custom synthesis
A sequence, a quantity and a specification go in; a written quotation comes back covering the accepted specification, timing, documentation and terms.
Hong Kong · Custom synthesis and volume research supply
Custom peptide synthesis and recurring research-material supply under written quotation.
PEPTAS supplies identified laboratory research materials under written quotation — custom-synthesized peptides, recurring volume requirements and a small held inventory. Synthesis, analytical testing and batch release are carried out by the production facility under contract. PEPTAS specifies each order, receives the release documentation and supplies under its own name and terms.
Request a quotationCustom synthesis capabilities
For qualified laboratory research only. Not for human or veterinary use.
Catalog identity records
Each published catalog entry states the identity fields verified for that entry
Operator
Ikigai Corporation Limited · Hong Kong BRN 69705679
Phase 1 build note, not published copy — cells withheld until the owner supplies the fact: Synthesis scale quoted [FACT: D-11] · Target purity [FACT: D-12]
Three ways to work with PEPTAS
Volume and recurring supply
Larger volumes and repeat schedules under a written arrangement, with forecast planning and batch documentation; a single point of contact is assigned when a supply arrangement is agreed.
Stock materials
A small held inventory of identified research materials supplied by Ikigai Corporation Limited under Hong Kong law, each with a complete identity record, each quoted on request.
Why a quotation, and not a price.
PEPTAS quotes every order in writing. What a material costs depends on the quantity, the pack format, the documentation you need and where it is going, and every request is reviewed before a quotation is issued. Tell us the material and the quantity, and after review PEPTAS may issue a written quotation covering price, availability, documentation and delivery basis, request further information or decline the request. If something is missing we ask before we quote.
A defined scope, stated once.
PEPTAS supplies
- custom-synthesized peptides to written specification
- recurring volume supply of identified research materials
- a held inventory of research materials
- a chemical identity record for every catalog material
- analytical documentation for the supplied material and batch as confirmed in the quotation
PEPTAS does not supply
- medicines, foods, supplements, cosmetics or veterinary products
- GMP or clinical-grade manufacturing
- material as an active pharmaceutical ingredient, or for incorporation into any product intended for human or animal use
- clinical, veterinary or diagnostic services
- dosing, administration or protocol advice
PEPTAS does not accept an order in which the material is represented, specified or intended for use as an active pharmaceutical ingredient.
Each complete request is reviewed before a quotation is issued.
From request to delivery
-
1
Request
Send the sequence or material, quantity, pack format, target purity, modifications, documentation and destination.
-
2
Review
Each complete request is reviewed before a quotation is issued. For custom synthesis, technical feasibility is confirmed through the contracted production facility before PEPTAS issues a quotation; PEPTAS separately reviews whether the request is consistent with its laboratory-research supply scope.
-
3
Quotation
A written quotation defines the specification, price, timing, documentation, delivery basis, destination admissibility and validity period.
-
4
Supply
On written acceptance, the order proceeds under the accepted quotation. Analytical documentation available for the material and batch is confirmed in the quotation.
When a form submission is successfully received, the system sends an acknowledgement carrying the request reference. The acknowledgement is not an order, a quotation or an acceptance. After review, PEPTAS may issue a written quotation, request further information or decline the request. Delivery timing is not quoted before review: it is fixed in the written quotation, together with the specification, price, documentation and delivery basis.
Every material has an identity record.
A chemical identity record establishes the stable reference fields for a catalog material. The formal name fixes the identity used in the record; the CAS number provides the registry identifier; the molecular formula states the elemental composition; and the molecular weight records the corresponding mass value. Together, these fields distinguish the requested material from similarly named or modified substances. The identity record is a catalog reference rather than a batch-specific analytical statement.
Analytical documentation available for the material and batch is confirmed in the quotation.
| Synonyms | Kisspeptin-10 (human) · human metastin 45-54 · KP-10 |
|---|---|
| CAS registry number | 374675-21-5 |
| Molecular formula | C63H83N17O14 |
| Molecular weight | 1302.5 g/mol (average) |
| Physical form | Lyophilized powder |
| Purity stated on packaging | ≥ 98.8% (HPLC) |
| Storage | Stored and shipped as stated on the packaging and in the order documentation. Quality and documentation |
| PubChem record | CID 25240297 View the PubChem record |
Handling sequence and project information.
Sequences and project details are used to assess and administer the request and any resulting order. They may be disclosed to the production facility engaged for the work and to service providers and professional advisers who need the information for those purposes and are subject to applicable confidentiality obligations. PEPTAS may retain or disclose information where reasonably required to establish, exercise or defend legal rights, comply with law or a court order, or respond to a lawful request or direction from Customs, a regulator or another competent authority.
A non-disclosure agreement may be agreed in writing before further confidential information is shared; if a sequence is confidential, submit an internal project reference and ask for the NDA first — a web form is not a substitute for an executed agreement. No non-disclosure agreement applies unless and until it has been executed by both parties.
Send only what a feasibility review needs. Please do not submit patient information, medical records, payment-card numbers, credentials, private keys or unrelated personal data through this site.
Phase 1 build note, not published copy — the conditional non-development sentence of PLAN.md 7.4 is withheld until the owner answers [FACT: D-41].
Who you are buying from.
| Legal name | Ikigai Corporation Limited |
|---|---|
| Business Registration No. | 69705679 |
| Trade mark | No. 306999635, registered to Ikigai Corporation Limited in classes 1, 16 and 25. The class 1 specification is limited to peptides for laboratory or scientific research, not for medical or veterinary purposes. |
| Registered office | Room 1213, 12/F., Tower A, Hunghom Commercial Centre, 39 Ma Tau Wai Road, Hunghom, Kowloon, Hong Kong |
Tell us what the project requires.
Include the material or sequence, quantity, target purity, documentation and destination. Submission creates a request for review only. Website content and form submission are not a quotation or a commitment to supply. After review, PEPTAS may issue a written quotation, request further information or decline the request.
